MX2017005828A - Unidad de farmaco-dispositivo que contiene quinagolida. - Google Patents
Unidad de farmaco-dispositivo que contiene quinagolida.Info
- Publication number
- MX2017005828A MX2017005828A MX2017005828A MX2017005828A MX2017005828A MX 2017005828 A MX2017005828 A MX 2017005828A MX 2017005828 A MX2017005828 A MX 2017005828A MX 2017005828 A MX2017005828 A MX 2017005828A MX 2017005828 A MX2017005828 A MX 2017005828A
- Authority
- MX
- Mexico
- Prior art keywords
- drug
- device unit
- poly
- quinagolide
- alkylene oxide
- Prior art date
Links
- GDFGTRDCCWFXTG-SCTDSRPQSA-N (3r,4ar,10as)-3-(diethylsulfamoylamino)-6-hydroxy-1-propyl-3,4,4a,5,10,10a-hexahydro-2h-benzo[g]quinoline Chemical compound C1=CC=C2C[C@@H]3N(CCC)C[C@H](NS(=O)(=O)N(CC)CC)C[C@H]3CC2=C1O GDFGTRDCCWFXTG-SCTDSRPQSA-N 0.000 title abstract 2
- 229960000924 quinagolide Drugs 0.000 title abstract 2
- 229920001400 block copolymer Polymers 0.000 abstract 3
- 229920000233 poly(alkylene oxides) Polymers 0.000 abstract 2
- 229920002635 polyurethane Polymers 0.000 abstract 2
- 239000004814 polyurethane Substances 0.000 abstract 2
- 201000009273 Endometriosis Diseases 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000012948 isocyanate Substances 0.000 abstract 1
- 150000002513 isocyanates Chemical class 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
- B29C48/001—Combinations of extrusion moulding with other shaping operations
- B29C48/0021—Combinations of extrusion moulding with other shaping operations combined with joining, lining or laminating
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2033/00—Use of polymers of unsaturated acids or derivatives thereof as moulding material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
- B29K2105/0005—Condition, form or state of moulded material or of the material to be shaped containing compounding ingredients
- B29K2105/0035—Medical or pharmaceutical agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- B29L2031/00—Other particular articles
- B29L2031/753—Medical equipment; Accessories therefor
- B29L2031/754—Pessaries
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Inorganic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Mechanical Engineering (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Materials For Medical Uses (AREA)
Abstract
La presente invención se basa en la identificación de una cohorte de copolímeros de bloque de poliuretano que son particularmente adecuados para el uso en unidades farmacéuticas de fármaco-dispositivo polimérico y los cuales ofrecen un control mejorado de la liberación del fármaco. En particular, se proporciona una unidad de fármaco-dispositivo polimérico que comprende un copolímero de bloque de poliuretano obtenible al hacer reaccionar conjuntamente un óxido de poli(alquileno); un compuesto difuncional; un isocianato difuncional; y opcionalmente un copolímero de bloque que comprende bloques de óxido de poli(alquileno); y quinagolida como un agente farmacéuticamente activo. Las unidades de fármaco-dispositivo pueden encontrar aplicación en el tratamiento y/o prevención de endometriosis.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14192372.2A EP3017809A1 (en) | 2014-11-07 | 2014-11-07 | Drug-device unit containing quinagolide |
PCT/EP2015/075849 WO2016071466A1 (en) | 2014-11-07 | 2015-11-05 | Drug-device unit containing quinagolide |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2017005828A true MX2017005828A (es) | 2017-11-13 |
Family
ID=51951583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2017005828A MX2017005828A (es) | 2014-11-07 | 2015-11-05 | Unidad de farmaco-dispositivo que contiene quinagolida. |
Country Status (33)
Country | Link |
---|---|
US (2) | US20180008535A1 (es) |
EP (3) | EP3017809A1 (es) |
JP (2) | JP6907120B2 (es) |
KR (1) | KR102612852B1 (es) |
CN (2) | CN116212032A (es) |
AR (1) | AR102571A1 (es) |
AU (2) | AU2015341734C1 (es) |
CA (1) | CA2966473A1 (es) |
CL (1) | CL2017001119A1 (es) |
CO (1) | CO2017005578A2 (es) |
DK (1) | DK3215118T3 (es) |
EA (2) | EA033806B9 (es) |
ES (1) | ES2877973T3 (es) |
HR (1) | HRP20210961T1 (es) |
HU (1) | HUE054951T2 (es) |
IL (1) | IL252088B (es) |
JO (1) | JO3561B1 (es) |
LT (1) | LT3215118T (es) |
MA (2) | MA40897B1 (es) |
MD (1) | MD3215118T2 (es) |
MX (1) | MX2017005828A (es) |
MY (1) | MY193638A (es) |
PH (1) | PH12017550005A1 (es) |
PL (1) | PL3215118T3 (es) |
PT (1) | PT3215118T (es) |
RS (1) | RS62018B1 (es) |
SA (1) | SA517381471B1 (es) |
SG (1) | SG11201703596SA (es) |
SI (1) | SI3215118T1 (es) |
TN (1) | TN2017000175A1 (es) |
TW (1) | TWI685339B (es) |
UA (1) | UA122329C2 (es) |
WO (1) | WO2016071466A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11896685B2 (en) | 2018-10-31 | 2024-02-13 | Amorepacific Corporation | Core-shell network structure comprising biopolymer and composition comprising same |
KR20210069344A (ko) | 2019-12-03 | 2021-06-11 | (주)아모레퍼시픽 | 바이오 폴리머를 포함하는 효능물질 전달체 |
WO2023031218A1 (en) | 2021-08-31 | 2023-03-09 | Ferring B.V. | Diagnosis and treatment of ectopic endometriosis |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4235988A (en) | 1976-12-13 | 1980-11-25 | Imperial Chemical Industries Limited | Delivery means for biologically active agents |
JP4898431B2 (ja) | 2003-04-29 | 2012-03-14 | ザ ジェネラル ホスピタル コーポレイション | 複数薬物の持続放出のための方法およびデバイス |
WO2005004837A1 (en) | 2003-07-10 | 2005-01-20 | Galen (Chemicals) Limited | Intravaginal drug delivery devices |
EP1682102A2 (en) * | 2003-09-10 | 2006-07-26 | Noven Pharmaceuticals, Inc. | Multi-layer transdermal drug delivery device |
CA2605972C (en) | 2005-04-29 | 2011-08-02 | Ferring International Center S.A. | Treatment or prevention of ovarian hyperstimulation syndrome (ohss) using a dopamine agonist |
GB0613638D0 (en) * | 2006-07-08 | 2006-08-16 | Controlled Therapeutics Sct | Polyurethane elastomers |
SA08290041B1 (ar) | 2007-02-01 | 2012-06-05 | فيرينج انترناشونال سنتر اس آيه | أدوية من أجل معالجة بطانة الرحم |
EP2249811A1 (en) * | 2008-01-25 | 2010-11-17 | Grünenthal GmbH | Pharmaceutical dosage form |
WO2009094573A2 (en) | 2008-01-25 | 2009-07-30 | The University Of Utah Research Foundation | Linear order release polymer |
US20100040671A1 (en) | 2008-08-12 | 2010-02-18 | Ahmed Salah U | Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof |
US20100210600A1 (en) * | 2009-02-19 | 2010-08-19 | Prelief Inc. | Methods and Compositions for Treating Urogenital Disorders |
TW201102066A (en) * | 2009-06-26 | 2011-01-16 | Ferring Int Ct Sa | Treatment of endometriosis |
CA2795289A1 (en) * | 2010-04-08 | 2011-10-13 | Sanford-Burnham Medical Research Institute | Methods and compositions for enhanced delivery of compounds |
US9393311B2 (en) | 2010-11-15 | 2016-07-19 | Dsm Ip Assets B.V. | Intravaginal ring comprising polyurethane composition for drug delivery |
EP2734262B1 (en) * | 2011-07-20 | 2018-02-28 | Patrick F. Kiser | Intravaginal rings for drug delivery |
US10137199B2 (en) * | 2013-05-14 | 2018-11-27 | Biotime, Inc. | Thiolated hyaluronan-based hydrogels cross-linked using oxidized glutathione |
US10413504B2 (en) * | 2013-12-11 | 2019-09-17 | Merck Sharp & Dohme Corp. | Intravaginal ring drug delivery system |
-
2014
- 2014-11-07 EP EP14192372.2A patent/EP3017809A1/en not_active Withdrawn
-
2015
- 2015-11-05 SI SI201531573T patent/SI3215118T1/sl unknown
- 2015-11-05 JP JP2017542330A patent/JP6907120B2/ja active Active
- 2015-11-05 AU AU2015341734A patent/AU2015341734C1/en active Active
- 2015-11-05 PL PL15790568T patent/PL3215118T3/pl unknown
- 2015-11-05 MX MX2017005828A patent/MX2017005828A/es unknown
- 2015-11-05 MY MYPI2017000673A patent/MY193638A/en unknown
- 2015-11-05 HU HUE15790568A patent/HUE054951T2/hu unknown
- 2015-11-05 MD MDE20170069T patent/MD3215118T2/ro unknown
- 2015-11-05 UA UAA201705500A patent/UA122329C2/uk unknown
- 2015-11-05 CN CN202310079847.2A patent/CN116212032A/zh active Pending
- 2015-11-05 PT PT157905688T patent/PT3215118T/pt unknown
- 2015-11-05 US US15/524,792 patent/US20180008535A1/en not_active Abandoned
- 2015-11-05 EP EP21162634.6A patent/EP3892261A1/en active Pending
- 2015-11-05 EA EA201790898A patent/EA033806B9/ru not_active IP Right Cessation
- 2015-11-05 SG SG11201703596SA patent/SG11201703596SA/en unknown
- 2015-11-05 EA EA201991882A patent/EA201991882A2/ru unknown
- 2015-11-05 CN CN201580067303.8A patent/CN106999422A/zh active Pending
- 2015-11-05 TN TN2017000175A patent/TN2017000175A1/en unknown
- 2015-11-05 RS RS20210767A patent/RS62018B1/sr unknown
- 2015-11-05 KR KR1020177015238A patent/KR102612852B1/ko active IP Right Grant
- 2015-11-05 JO JOP/2015/0276A patent/JO3561B1/ar active
- 2015-11-05 DK DK15790568.8T patent/DK3215118T3/da active
- 2015-11-05 MA MA40897A patent/MA40897B1/fr unknown
- 2015-11-05 WO PCT/EP2015/075849 patent/WO2016071466A1/en active Application Filing
- 2015-11-05 ES ES15790568T patent/ES2877973T3/es active Active
- 2015-11-05 CA CA2966473A patent/CA2966473A1/en active Pending
- 2015-11-05 LT LTEP15790568.8T patent/LT3215118T/lt unknown
- 2015-11-05 MA MA056414A patent/MA56414A/fr unknown
- 2015-11-05 EP EP15790568.8A patent/EP3215118B1/en active Active
- 2015-11-06 AR ARP150103620A patent/AR102571A1/es unknown
- 2015-11-06 TW TW104136694A patent/TWI685339B/zh active
-
2017
- 2017-05-03 IL IL252088A patent/IL252088B/en unknown
- 2017-05-05 PH PH12017550005A patent/PH12017550005A1/en unknown
- 2017-05-05 CL CL2017001119A patent/CL2017001119A1/es unknown
- 2017-05-06 SA SA517381471A patent/SA517381471B1/ar unknown
- 2017-06-05 CO CONC2017/0005578A patent/CO2017005578A2/es unknown
-
2020
- 2020-11-17 AU AU2020270480A patent/AU2020270480A1/en not_active Abandoned
-
2021
- 2021-05-10 US US17/316,208 patent/US20220040094A1/en not_active Abandoned
- 2021-06-16 HR HRP20210961TT patent/HRP20210961T1/hr unknown
- 2021-06-30 JP JP2021108386A patent/JP2021155444A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TN2017000506A1 (en) | Adenoassociated virus vectors for the treatment of mucopolysaccharidoses | |
MX2018008190A (es) | Sistemas y metodos para la administracion transdermica a largo plazo. | |
MY187540A (en) | Compounds active towards bromodomains | |
GB201704205D0 (en) | Opthalmic delivery device and opthalmic active agent containing compositions | |
MX2016012574A (es) | Compuestos heteroarilo sustituidos y metodos de uso. | |
MY183472A (en) | Adenoassociated virus vectors for the treatment of lysosomal storage disorders | |
MX2018001453A (es) | Nuevas formulaciones para adhesivos sensibles a la presion. | |
PH12017550005A1 (en) | Drug-device unit containing quinagolide | |
MX2017003623A (es) | Parche de opipramol. | |
MX2016009248A (es) | Compuestos que contienen nitrogeno y su uso como agentes antibacterianos. | |
EP3431517A4 (en) | Copolymer and surface treatment | |
ZA202006415B (en) | Tetrabenazine transdermal delivery device | |
HK1254354A1 (zh) | 包括給予2-氨基-3,5,5-三氟-3,4,5,6-四氫吡啶的聯合治療 | |
FR3044663B1 (fr) | Copolymere monofonctionnel ou telechelique de 1,3-butadiene et d'ethylene. | |
PH12016502236A1 (en) | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
EP3600306A4 (en) | AGENT FOR PREVENTION OF MYOPIA, TREATMENT OF MYOPIA, AND / OR PREVENTION OF THE PROGRESSION OF MYOPIA INCLUDING TIOTROPIUM AS ACTIVE INGREDIENT | |
TH1701002526A (th) | หน่วยอุปกรณ์ส่งยาที่มีควินาโกไลด์ | |
SG11202003797VA (en) | Polymeric compositions, delivery devices, and methods | |
RS65225B1 (sr) | Lek za lečenje i/ili prevenciju endometrioze | |
MX369464B (es) | Espumas liofilizadas de polímeros absorbibles que contienen bloques de extremo. | |
UA106131U (uk) | Медикаментозна збовтувана композиція для локальної терапії гангрени фурн'є | |
MX2017001512A (es) | Compuestos activos hacia bromodominios. |